Trial Profile
A randomized, placebo-controlled study to evaluate the protective effect of ulinastatin in patients with non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Ulinastatin (Primary)
- Indications Lung injury
- Focus Therapeutic Use
- 05 Feb 2016 New trial record